Genomic & Biopharma News

Editor's Corner: Who are the most influential people in biopharma today? We're asking you
Editor's Corner: Who are the most influential people in biopharma today? We're asking you chelfand Tue, 02/07/2017 - 09:34
Fierce Pharma, 2017-02-07 14:34:18

Mylan signs off on $96.5M Provigil pay-for-delay settlement
Mylan signs off on $96.5M Provigil pay-for-delay settlement esagonowsky Tue, 02/07/2017 - 09:32
Fierce Pharma, 2017-02-07 14:32:39

Value investors pile into Gilead expecting strong long-term growth: report
Value investors pile into Gilead expecting strong long-term growth: report arlene.weintraub Tue, 02/07/2017 - 09:32
Fierce Pharma, 2017-02-07 14:32:21

Biotech leaders take on Trump’s immigration ban, warn of mounting harm
Biotech leaders take on Trump’s immigration ban, warn of mounting harm badams Tue, 02/07/2017 - 09:27
Fierce Biotech, 2017-02-07 14:27:12

Catalent beats on revenues and earnings ahead of closing Accucaps deal
Catalent beats on revenues and earnings ahead of closing Accucaps deal epalmer Tue, 02/07/2017 - 09:21
Fierce Pharma, 2017-02-07 14:21:06

Valo Therapeutics Developing Unique Viral-particle Cancer Vaccine

Immuno-Oncology News, 2017-02-07 14:19:10

Renova takes over Janssen's rights to heart failure candidate stresscopin
Renova takes over Janssen's rights to heart failure candidate stresscopin phil Tue, 02/07/2017 - 08:45
Fierce Biotech, 2017-02-07 13:45:07

LocExpress – a web server for efficiently estimating expression of novel transcripts
The temporal and spatial-specific expression pattern of a transcript in multiple tissues and cell types can indicate key clues about its function. While several gene atlas available online as pre-computed databases for known gene models, it’s still challenging to obtain expression profiles for previously uncharacterized (i.e. novel) transcripts efficiently. Now, researchers from Peking University have ...
Transcriptome Research & Industry News, 2017-02-07 13:30:08

Teva CEO Vigodman exits, piling uncertainty onto the struggling drugmaker
Teva CEO Vigodman exits, piling uncertainty onto the struggling drugmaker chelfand Tue, 02/07/2017 - 08:17
Fierce Pharma, 2017-02-07 13:17:00